BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21879827)

  • 1. Safety of tranexamic acid in women with heavy menstrual bleeding: an open-label extension study.
    Lukes AS; Freeman EW; Van Drie D; Baker J; Adomako TL
    Womens Health (Lond); 2011 Sep; 7(5):591-8. PubMed ID: 21879827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of safety and health-related quality of life in women with heavy menstrual bleeding treated with oral tranexamic acid.
    Muse K; Lukes AS; Gersten J; Waldbaum A; Mabey RG; Trott E
    Womens Health (Lond); 2011 Nov; 7(6):699-707. PubMed ID: 21867401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.
    Lukes AS; Moore KA; Muse KN; Gersten JK; Hecht BR; Edlund M; Richter HE; Eder SE; Attia GR; Patrick DL; Rubin A; Shangold GA
    Obstet Gynecol; 2010 Oct; 116(4):865-875. PubMed ID: 20859150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral modified-release tranexamic acid for heavy menstrual bleeding.
    Hrometz SL
    Ann Pharmacother; 2012; 46(7-8):1047-53. PubMed ID: 22811348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding.
    Moore KA; Morin I; Marenco T; Lavigne JR; Morelli G
    Am J Ther; 2012 May; 19(3):190-8. PubMed ID: 21248612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid increases hemoglobin and ferritin levels in women with heavy menstrual bleeding.
    Muse K; Mabey RG; Waldbaum A; Gersten JK; Adomako TL
    J Womens Health (Larchmt); 2012 Jul; 21(7):756-61. PubMed ID: 22428868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrinolytics in women with menorrhagia.
    Philipp CS
    Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
    Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
    Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid.
    Goshtasebi A; Moukhah S; Gandevani SB
    Arch Gynecol Obstet; 2013 Nov; 288(5):1055-60. PubMed ID: 23595582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding.
    Winkler UH
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):238-43. PubMed ID: 11788179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid: a review of its use in the management of menorrhagia.
    Wellington K; Wagstaff AJ
    Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid: a new option for heavy menstrual bleeding.
    Wilton JM
    Nurs Womens Health; 2012; 16(2):146-150. PubMed ID: 22900772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding.
    Lukes AS; Kouides PA; Moore KA
    Womens Health (Lond); 2011 Mar; 7(2):151-8. PubMed ID: 21410342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding.
    Moore KA; Callahan TS; Maison-Blanche P; Morin I; Marenco T; Swearingen D; Olbertz J
    Expert Opin Pharmacother; 2010 Oct; 11(14):2281-90. PubMed ID: 20698724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia.
    Preston JT; Cameron IT; Adams EJ; Smith SK
    Br J Obstet Gynaecol; 1995 May; 102(5):401-6. PubMed ID: 7612535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
    Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids.
    Eder S; Baker J; Gersten J; Mabey RG; Adomako TL
    Womens Health (Lond); 2013 Jul; 9(4):397-403. PubMed ID: 23656203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid therapy for heavy menstrual bleeding.
    Lumsden MA; Wedisinghe L
    Expert Opin Pharmacother; 2011 Sep; 12(13):2089-95. PubMed ID: 21767224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.